Division of Vascular Surgery, Department of Surgery, VU University Medical Centre, Amsterdam, Utrecht, The Netherlands.
Br J Surg. 2013 Oct;100(11):1465-70. doi: 10.1002/bjs.9280.
Deterioration of renal function after major vascular surgery is an important complication, and may vary between patients undergoing endovascular (EVAR) or open surgical (OR) repair of an abdominal aortic aneurysm (AAA). The objective was to determine the impact of OR and EVAR on renal function after 5 years.
This was a post hoc analysis of data collected prospectively from the Dutch Randomized Endovascular Aneurysm Management (DREAM) trial. Five years after surgery, creatinine levels were available for 189 patients (94 after OR and 95 after EVAR). The severity of renal disease was staged using the chronic kidney disease classification of the US National Kidney Foundation clinical guidelines.
Using the Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) equation, the estimated glomerular filtration rate (eGFR) for the entire group declined over time, with a mean(s.d.) preoperative value of 80·0(7·6) ml per min per 1·73 m(2) compared with 75·7(9·7) ml per min per 1·73 m(2) after 5 years (mean difference 4·2 (95 per cent confidence interval 3·2 to 5·3) ml per min per 1·73 m(2) ; P < 0·001). Five years after surgery, the mean eGFR (CKD-EPI equation) was not significantly different between the OR and EVAR groups: 76·3(9·3) versus 75·1(10·0) ml per min per 1·73 m(2) (mean difference 1·2 (-1·6 to 3·9) ml per min per 1·73 m(2) ; P = 0·410).
Renal function 5 years after OR and EVAR for AAA was similar. Neither surgical procedure accelerated the loss of renal function.
大血管手术后肾功能恶化是一种重要的并发症,接受腹主动脉瘤(AAA)血管内(EVAR)或开放手术(OR)修复的患者之间可能存在差异。目的是确定 OR 和 EVAR 对 5 年后肾功能的影响。
这是对荷兰随机血管内动脉瘤管理(DREAM)试验前瞻性收集的数据进行的事后分析。手术后 5 年,189 名患者(OR 后 94 名,EVAR 后 95 名)可获得肌酐水平。使用美国国家肾脏基金会临床指南的慢性肾脏病分类对肾脏疾病的严重程度进行分期。
使用慢性肾脏病流行病学合作(CKD-EPI)方程,整个组的估计肾小球滤过率(eGFR)随时间推移而下降,术前平均值(标准差)为 80·0(7·6)ml/min/1·73 m(2),而术后 5 年为 75·7(9·7)ml/min/1·73 m(2)(平均差异 4·2(95%置信区间 3·2 至 5·3)ml/min/1·73 m(2);P<0·001)。手术后 5 年,OR 和 EVAR 组之间的平均 eGFR(CKD-EPI 方程)无显著差异:76·3(9·3)与 75·1(10·0)ml/min/1·73 m(2)(平均差异 1·2(-1·6 至 3·9)ml/min/1·73 m(2);P=0·410)。
AAA 术后 5 年 OR 和 EVAR 治疗后的肾功能相似。两种手术均未加速肾功能丧失。